Comparing interventions for chronic central serous chorioretinopathy: A network meta-analysis
Open Access
- 15 March 2023
- journal article
- review article
- Published by Elsevier in Survey of Ophthalmology
- Vol. 68 (4) , 601-614
Abstract
No abstract availableKeywords
Funding Information
- Université Laval
This publication has 48 references indexed in Scilit:
- Intravitreal bevacizumab versus low-fluence photodynamic therapy for treatment of chronic central serous chorioretinopathyJapanese Journal of Ophthalmology, 2012
- A Randomized Pilot Study of Low-Fluence Photodynamic Therapy Versus Intravitreal Ranibizumab for Chronic Central Serous ChorioretinopathyAmerican Journal of Ophthalmology, 2011
- The Cochrane Collaboration's tool for assessing risk of bias in randomised trialsBMJ, 2011
- Transforming scales of measurement of visual acuity at the group levelOphthalmic and Physiological Optics, 2010
- Selective retina therapy for acute central serous chorioretinopathyBritish Journal of Ophthalmology, 2010
- Severe choroidal ischemia following Photodynamic Therapy for pigment epithelial detachment and chronic central serous chorioretinopathyJapanese Journal of Ophthalmology, 2009
- Central serous chorioretinopathyActa Ophthalmologica, 2008
- Risk factors for central serous chorioretinopathyOphthalmology, 2004
- Choroidal vascular remodelling in central serous chorioretinopathy after indocyanine green guided photodynamic therapy with verteporfin: a novel treatment at the primary disease levelBritish Journal of Ophthalmology, 2003
- A computerized method of visual acuity testingAmerican Journal of Ophthalmology, 2003